Navigation Links
Governor presents UH researcher with grant for cardiac device
Date:10/8/2010

HOUSTON, Oct. 7, 2010 As more and more medical care is provided in the home, health specialists say it is critical for people to be able to monitor themselves and make informed judgments about their health. A group of researchers in the Abramson Center for the Future of Health at the University of Houston (UH) received a $250,000 pre-seed grant from the Texas Emerging Technology Fund (ETF) for a system that assesses cardiac function in the home and alerts the user to the need for intervention. Upon reaching specific milestones with the project, the researchers will receive the remaining $750,000 of the $1 million grant.

At the core of the system is a novel, patent-pending device called Blue Scale. It is very simple in its design and wirelessly sends key readings of cardiac output data and other related statistics on a patient's condition to company servers that then use proprietary predictive analytics to warn physicians. By alerting doctors in a targeted manner to important changes in patient status that can be managed more immediately on an ongoing basis, medical professionals will be better able to manage care in a realistic everyday environment the patient's home and anticipate deadly heart failure emergencies, ultimately reducing the likelihood of hospitalization.

Dr. Cliff Dacso, a professor in UH's College of Technology and executive director of the Abramson Center, leads the research and is working through Blue Box Health Inc. to commercialize the device. In addition to a number of colleagues at the Methodist Hospital Research Institute (TMHRI), Dacso is working with Nithin Rajan from UH's Bauer College of Business and Luca Pollonini from the department of engineering technology, also in the College of Technology. The Abramson Center is a collaboration between TMHRI and UH.

The Blue Scale, which looks like a souped-up bathroom scale, was invented for the non-invasive, continuous monitoring of chronic conditions in the comfort of a person's own home, putting some control into the hands of patients and giving doctors real-time information on their conditions for better evaluation and treatment. Driven by biosensors, it consists of a bathroom scale attached to handlebars that monitor vitals through vessels in the hands via biosensor strips and a pulse monitor. The device is designed for usability in an elderly population, with the base being reinforced and handles large enough for a person to support themselves.

The device is first being used for the wireless management of congestive heart failure, with hopes of expanding on the basic system to monitor asthma and metabolic syndrome, allowing patients to participate more actively in their own chronic disease care. Tracking output of blood from the heart, the Blue Scale reads heart rate, fluid retention and cardiac output in just 15 seconds. The information the device collects on a daily basis is transferred via Wi-Fi network to the doctor's office for continuous, real-time monitoring and is reflected back to the patient in a user-friendly manner. The developers of Blue Scale say it's a life-saving tool that puts power back in the hands of patients, which is a top priority of the Abramson Center.

"Our development of this low-cost, easy-to-use monitoring device will make personalized health care much more accessible," said Dacso, who is also the John S. Dunn Senior Research Chair in General Internal Medicine at TMHRI. "This technology is designed to allow people with chronic illnesses to fine-tune their health, thus avoiding preventable deterioration that may result in emergency care. It's much easier on the patient and provides them with higher quality and very personal care, since markers for chronic disease are measured every day, rather than only during physician visits or crises. When caught earlier, symptoms can be managed more easily and improve quality of life."

With approximately 50 companies competing for this latest round of ETF disbursements, Dacso's company Blue Box Health emerged as one of the nine finalists, of which only four received grants for developing and commercializing their biomedical technologies. The ETF is a means to strengthen Texas' high-tech economy by supporting promising technologies during the critical phase between earliest innovation and market viability.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. Governor Quinn Declares “Nothing But Nets” Week
2. Media Advisory: Wisconsin Governor, Legislators to be Honored for Seat Belt law
3. Governor Tim Pawlenty Issues Proclamation Making Thursday, March 25, 2010 Medical Biller's Day
4. Little City Foundation Battles for Rights of Individuals with Disabilities in Springfield and Meets with Legislators Day Before Governors Budget Address
5. North American Spine Joins Governor Arnold Schwarzenegger at 2010 ICA Symposium
6. In-Home Caregivers Join in March and Launch Campaign to Stop Governors Cuts
7. AMA Honors Maine Governor John Baldacci With Top Government Service Award
8. Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut
9. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
10. Governor Rendell Proposes Budget With No Tax Increase, More Money for Public Schools, Strategy for Jobs, Plan to Address Future Deficits
11. Onconova Therapeutics presents new data demonstrating radioprotection by Ex-RAD at RRS annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Governor presents UH researcher with grant for cardiac device
(Date:3/29/2017)... Illinois (PRWEB) , ... March 29, 2017 , ... ... Stencils Device Library for documenting and diagramming network and data center assets and ... , NetZoom subscribers can request new equipment shapes for free and download shapes ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... Richmond, VA (PRWEB) , ... March 29, 2017 , ... ... of its seventh North American office location in Richmond, Virginia, located at the Riverfront ... April 11, attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is the first technology to directly address the resolution to globally reduce the ... is a patented compound of FDA and TTB approved ingredients that when infused ...
(Date:3/28/2017)... ... 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid ... Thyroid Secret. Dr. Wentz talked about journey and research recently on a blog and ... NOT the only solution to deal with thyroid disease. , Dr. Wentz completed ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care ... a new PhRMA report on patient out-of-pocket spending: ... Medicare and Medicaid Services (CMS), the average amount spent ... 13% of drug spending in 2016, down from 23% ... a pricing problem, not a coverage problem. Health plans ...
(Date:3/29/2017)... March 29, 2017  Designers of primary cell wearable ... size by 50% and extend battery life with the ... integrated circuit (PMIC) from Maxim Integrated Products, Inc. (NASDAQ: ... low input voltage of just 0.7V for new high-energy ... Oxide, as well as the more common Alkaline battery ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: